Table 1 Pathological characteristics of the study group
From: Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients
Variables | Study group (n = 70) | |
|---|---|---|
No | % | |
Lobe | ||
 RT | 27 | 38.6 |
 LT | 43 | 61.4 |
Size | 6.40 ± 2.82 | |
Pathological parameters | ||
Necrosis | ||
 Yes | 29 | 41.4 |
 No | 41 | 58.6 |
Microscopic vascular emboli | ||
 Yes | 26 | 37.1 |
 No | 44 | 62.9 |
Grading | ||
 1 | 37 | 52.9 |
 2 | 19 | 27.1 |
 3 | 14 | 20.0 |
Mitotic count | Median = 2, min-max (1–54) | |
Decompensation | ||
 Yes | 20 | 28.6 |
 No | 50 | 71.4 |
Overall survival | Â | |
 Median (min-max) | 7 (1–40) | |
Local recurrence | ||
 Yes | 17 | 24.3 |
 No | 53 | 75.7 |
The onset of local recurrence after resection | ||
 Median (min-max) | 3 (1–36) | |
Metastasis | ||
 Yes | 6 | 8.6 |
 No | 64 | 91.4 |
Growth pattern | Â | Â |
 Trabecular | 40 | 57.1 |
 Trabecular & acinar | 25 | 35.7 |
 Diffuse | 2 | 2.9 |
 Pseudo acinar | 2 | 2.9 |
 Solid | 1 | 1.4 |